Upon fusion with macrophages, both MCF-7 and MDA-MB-231 cells had a higher percentage of CD44+/CD24−cells and enhanced tumorigenicity in vivo, suggesting that cell fusion can also be a source of cancer stem cells (CSCs). This evidence concerns the gene CD44 and cancer.